Pedro Enrique
Mondejar Lopez
Asociado Ciencias de la Salud
Publicacions (37) Publicacions de Pedro Enrique Mondejar Lopez
2024
-
Maternal and fetal outcomes in multiparous women with Cystic Fibrosis
Respiratory Medicine, Vol. 228
2023
-
SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge
Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205
2022
-
Analysis of the genotypic profile and its relationship with the clinical manifestations in people with cystic fibrosis: study from a rare disease registry
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
-
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation A Phase 3b, Randomized, Placebo-controlled Study
American Journal of Respiratory and Critical Care Medicine, Vol. 206, Núm. 11, pp. 1361-1369
-
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
Journal of Cystic Fibrosis, Vol. 21, Núm. 4, pp. e221-e231
-
Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation
Respiratory Medicine, Vol. 192
-
Incidence and Prevalence of Children's Diffuse Lung Disease in Spain
Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 22-29
2021
-
A multimodal approach to detect and monitor early lung disease in cystic fibrosis
Expert Review of Respiratory Medicine, Vol. 15, Núm. 6, pp. 761-772
-
COVID-19 vaccine prioritisation for people with cystic fibrosis
Journal of Cystic Fibrosis
-
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
Journal of Cystic Fibrosis, Vol. 20, Núm. 1, pp. 25-30
-
Factors associated to functional recovery of left vocal fold motion impairment at two-years-old age in very preterm infants
International Journal of Pediatric Otorhinolaryngology, Vol. 142
-
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
Journal of Cystic Fibrosis, Vol. 20, Núm. 4, pp. 566-577
2020
-
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
Respiratory Medicine, Vol. 170
-
Impact of early caffeine therapy in preterm newborns on infant lung function
Pediatric Pulmonology, Vol. 55, Núm. 1, pp. 102-107
-
Preschool asthma symptoms in children born preterm: The relevance of lung function in infancy
Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-8
-
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
Journal of Cystic Fibrosis, Vol. 19, Núm. 6, pp. 868-871
2019
-
Follow-up protocol of patients with cystic fibrosis diagnosed by newborn screening
Anales de Pediatria, Vol. 90, Núm. 4, pp. 251.e1-251.e10
-
Malformaciones pulmonares congénitas
Manual de pediatría (Ergon), pp. 983-989
-
Protocolo de seguimiento de pacientes con fibrosis quística diagnosticados por cribado neonatal
Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 90, Núm. 4, pp. 251-251
-
Spanish multicentre study on morbidity and pathogenicity of tracheal bronchus in children
Pediatric Pulmonology, Vol. 54, Núm. 10, pp. 1610-1616